127 related articles for article (PubMed ID: 23754945)
1. Shigella IpaH0722 E3 ubiquitin ligase effector targets TRAF2 to inhibit PKC-NF-κB activity in invaded epithelial cells.
Ashida H; Nakano H; Sasakawa C
PLoS Pathog; 2013; 9(6):e1003409. PubMed ID: 23754945
[TBL] [Abstract][Full Text] [Related]
2. TRIM47 is a novel endothelial activation factor that aggravates lipopolysaccharide-induced acute lung injury in mice via K63-linked ubiquitination of TRAF2.
Qian Y; Wang Z; Lin H; Lei T; Zhou Z; Huang W; Wu X; Zuo L; Wu J; Liu Y; Wang LF; Guan XH; Deng KY; Fu M; Xin HB
Signal Transduct Target Ther; 2022 May; 7(1):148. PubMed ID: 35513381
[TBL] [Abstract][Full Text] [Related]
3. TRAF2 is an NF-κB-activating oncogene in epithelial cancers.
Shen RR; Zhou AY; Kim E; O'Connell JT; Hagerstrand D; Beroukhim R; Hahn WC
Oncogene; 2015 Jan; 34(2):209-16. PubMed ID: 24362534
[TBL] [Abstract][Full Text] [Related]
4. Posttranscriptional downregulation of c-IAP2 by the ubiquitin protein ligase c-IAP1 in vivo.
Conze DB; Albert L; Ferrick DA; Goeddel DV; Yeh WC; Mak T; Ashwell JD
Mol Cell Biol; 2005 Apr; 25(8):3348-56. PubMed ID: 15798218
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of the substrate-recognition domain of the Shigella E3 ligase IpaH9.8.
Takagi K; Kim M; Sasakawa C; Mizushima T
Acta Crystallogr F Struct Biol Commun; 2016 Apr; 72(Pt 4):269-75. PubMed ID: 27050259
[TBL] [Abstract][Full Text] [Related]
6. WSB1/2 target chromatin-bound lysine-methylated RelA for proteasomal degradation and NF-κB termination.
Zhang J; Yu Y; Zou X; Du Y; Liang Q; Gong M; He Y; Luo J; Wu D; Jiang X; Sinclair M; Tajkhorshid E; Chen HZ; Hou Z; Zheng Y; Chen LF; Yang XD
Nucleic Acids Res; 2024 May; 52(9):4969-4984. PubMed ID: 38452206
[TBL] [Abstract][Full Text] [Related]
7. The Shigella kinase effector OspG modulates host ubiquitin signaling to escape septin-cage entrapment.
Xian W; Fu J; Zhang Q; Li C; Zhao YB; Tang Z; Yuan Y; Wang Y; Zhou Y; Brzoic PS; Zheng N; Ouyang S; Luo ZQ; Liu X
Nat Commun; 2024 May; 15(1):3890. PubMed ID: 38719850
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin-mediated NFκB degradation pathway.
Xu H; You M; Shi H; Hou Y
Cell Mol Immunol; 2015 Nov; 12(6):653-5. PubMed ID: 25345807
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic ubiquitination of GSDMB inhibits NK cell bactericidal functions.
Hansen JM; de Jong MF; Wu Q; Zhang LS; Heisler DB; Alto LT; Alto NM
Cell; 2021 Jun; 184(12):3178-3191.e18. PubMed ID: 34022140
[TBL] [Abstract][Full Text] [Related]
10. Shigella IpaH7.8 E3 ubiquitin ligase targets glomulin and activates inflammasomes to demolish macrophages.
Suzuki S; Mimuro H; Kim M; Ogawa M; Ashida H; Toyotome T; Franchi L; Suzuki M; Sanada T; Suzuki T; Tsutsui H; Núñez G; Sasakawa C
Proc Natl Acad Sci U S A; 2014 Oct; 111(40):E4254-63. PubMed ID: 25246571
[TBL] [Abstract][Full Text] [Related]
11. Manipulation of the host cell death pathway by Shigella.
Ashida H; Kim M; Sasakawa C
Cell Microbiol; 2014 Dec; 16(12):1757-66. PubMed ID: 25264025
[TBL] [Abstract][Full Text] [Related]
12. Shigella hacks host immune responses by reprogramming the host epigenome.
Ashida H; Sasakawa C
EMBO J; 2014 Nov; 33(22):2598-600. PubMed ID: 25246515
[TBL] [Abstract][Full Text] [Related]
13. Exploiting bacterial effector proteins to uncover evolutionarily conserved antiviral host machinery.
Embry A; Baggett NS; Heisler DB; White A; de Jong MF; Kocsis BL; Tomchick DR; Alto NM; Gammon DB
PLoS Pathog; 2024 May; 20(5):e1012010. PubMed ID: 38753575
[TBL] [Abstract][Full Text] [Related]
14.
Byerly CD; Zhu B; Warwick PA; Patterson LL; Pittner NA; McBride JW
Front Cell Dev Biol; 2024; 12():1327418. PubMed ID: 38562145
[No Abstract] [Full Text] [Related]
15. NLRP6 induces RIP1 kinase-dependent necroptosis via TAK1-mediated p38
Deng Q; Yang S; Huang K; Zhu Y; Sun L; Cao Y; Dong K; Li Y; Wu S; Huang R
iScience; 2024 Apr; 27(4):109339. PubMed ID: 38500819
[TBL] [Abstract][Full Text] [Related]
16. Exploiting Bacterial Effector Proteins to Uncover Evolutionarily Conserved Antiviral Host Machinery.
Embry A; Baggett NS; Heisler DB; White A; de Jong MF; Kocsis BL; Tomchick DR; Alto NM; Gammon DB
bioRxiv; 2024 Jan; ():. PubMed ID: 38352400
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin-Dependent and Independent Proteasomal Degradation in Host-Pathogen Interactions.
Bialek W; Collawn JF; Bartoszewski R
Molecules; 2023 Sep; 28(18):. PubMed ID: 37764516
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin-targeted bacterial effectors: rule breakers of the ubiquitin system.
Roberts CG; Franklin TG; Pruneda JN
EMBO J; 2023 Sep; 42(18):e114318. PubMed ID: 37555693
[TBL] [Abstract][Full Text] [Related]
19. A hierarchy of cell death pathways confers layered resistance to shigellosis in mice.
Roncaioli JL; Babirye JP; Chavez RA; Liu FL; Turcotte EA; Lee AY; Lesser CF; Vance RE
Elife; 2023 Jan; 12():. PubMed ID: 36645406
[TBL] [Abstract][Full Text] [Related]
20. Immune evasion and persistence in enteric bacterial pathogens.
J Worley M
Gut Microbes; 2023; 15(1):2163839. PubMed ID: 36617629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
